Agreed, Zoli... a nice synopsis as usual. My b
Post# of 36537
(Total Views: 244)
Posted On: 08/21/2020 2:36:02 PM
Re: Zolis_onkel #20077
Agreed, Zoli... a nice synopsis as usual.
My best understanding from reading the S1 and from others’ posts is that the 5MM in shares from the first set of warrants is in play, but the others are “on the shelf” if Joe needs them (after the approval of any/all of these S1s. It is my hope that Joe doesn’t need to access most of this capital and this is a case of “Break glass in case of emergency” option.
That said, I feel we need some real clarity from Joe in the call/s, and we should pursue this issue until we can better understand the likelihood of massive dilution. It is again my hope that the NGIO listing will occur and render ALL of these options unnecessary by providing Joe the working capital he needs.
All that said, none of this is approved. I don’t envy the SEC trying to process all of this. Even though it is their job to understand these, and they look at things such as this on a daily basis, I can understand how there is no rapidity to our approvals due to the complexity.
My best understanding from reading the S1 and from others’ posts is that the 5MM in shares from the first set of warrants is in play, but the others are “on the shelf” if Joe needs them (after the approval of any/all of these S1s. It is my hope that Joe doesn’t need to access most of this capital and this is a case of “Break glass in case of emergency” option.
That said, I feel we need some real clarity from Joe in the call/s, and we should pursue this issue until we can better understand the likelihood of massive dilution. It is again my hope that the NGIO listing will occur and render ALL of these options unnecessary by providing Joe the working capital he needs.
All that said, none of this is approved. I don’t envy the SEC trying to process all of this. Even though it is their job to understand these, and they look at things such as this on a daily basis, I can understand how there is no rapidity to our approvals due to the complexity.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼